ARCHIVES

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Warns Of Pill’s Potential Tumor Threat

April 2, 1976

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

NCAB Shaping Up, But Reverts to Nonsense When Discussing “Role Of The Board”

March 11, 1983